Evaluation of success and toxicity of autologous stem cell transplantation in patients with multiple myeloma in the geriatric age group
<p><strong>Background</strong>: Our objective in this study is to compare the outcomes of patients with multiple myeloma (MM) over 65 years of age who had autologous hematopoietic stem cell transplantation (AHSCT) with the outcomes of patients under 65 years of age.</p><p&...
Saved in:
Main Authors: | Mehmet Ali Uçar (Author), Simten Dağdaş (Author), Funda Ceran (Author), Mesude Falay (Author), Gülsüm Özet (Author) |
---|---|
Format: | Book |
Published: |
Studies on Stem Cells Research and Therapy - Peertechz Publications,
2019-08-03.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Autologous Stem Cell Transplantation in Multiple Myeloma with Renal Failure: Friend or Foe?
by: Hongfei Zhong, et al.
Published: (2019) -
Plerixafor in non-Hodgkin's lymphoma and multiple myeloma patients undergoing autologous stem cell transplantation
by: Jan S. Moreb
Published: (2011) -
Changes in Laboratory Indexes for Multiple Myeloma Patients Before and After Autologous Stem Cell Transplant
by: Zhao R, et al.
Published: (2023) -
Autologous Bone Marrow Transplant in Multiple Myeloma Patient With Bone Marrow Hematopoietic Stem Cell
by: D Santosa, et al.
Published: (2020) -
The efficacy and safety of second salvage autologous transplantation in myeloma patients
by: Reka Rahel Bicsko, et al.
Published: (2024)